Curis Lifesciences Limited (NSE:CURIS)

Market Cap	753.87M
Revenue (ttm)	496.32M +133.5%
Net Income	61.05M +1,100.6%
EPS	10.29 +1,012.8%
Shares Out	8.08M
PE Ratio	9.06
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,000
Average Volume	19,900
Open	95.50
Previous Close	99.90
Day's Range	89.75 - 95.50
52-Week Range	83.60 - 147.90
Beta	n/a
RSI	46.02
Earnings Date	May 29, 2026

About Curis Lifesciences

Curis Lifesciences Limited operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India. The company's business model operates through loan license manufacturing, through which, the company carry outs manufacturing under Loan License arrangement for domestic suppliers, where all raw materials and excipients are procured and delivered by the client; contract manufacturing, where the comp...

• Industry: Commercial Physical and Biological Research
• Founded: 2010
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: CURIS

Financial Performance

In fiscal year 2025, Curis Lifesciences's revenue was 496.32 million, an increase of 39.59% compared to the previous year's 355.56 million. Earnings were 61.05 million, an increase of 25.44%.